Get the Stockscreener App
2.03
2.01%
0.04
After Hours:
2.03
Immutep Limited Adr Stock (IMMP) Latest News
Immutep Quarterly Activities Report Q1 FY25 - GlobeNewswire
Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - The Manila Times
Immutep to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewswire Inc.
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Metric Deep Dive: Understanding Immutep Limited ADR (IMMP) Through its Ratios - The Dwinnex
Immutep reports positive results in cancer study - Investing.com
Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September - Benzinga
Research Analysts Issue Forecasts for Immutep Limited’s FY2025 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited ADR (IMMP) Stock: Navigating a Year of Volatility - The InvestChronicle
Short Interest in Immutep Limited (NASDAQ:IMMP) Declines By 10.1% - Defense World
Immutep Announces First Participant Dosed in Phase I Study of IMP761, a First in Class Agonist LAG-3 Antibody - GlobeNewswire
Virtu Financial LLC Buys 32,864 Shares of Immutep Limited (NASDAQ:IMMP) - Defense World
Immutep reports steady progress in Q4 FY24 - Investing.com India
Immutep reports steady progress in Q4 FY24 By Investing.com - Investing.com Australia
Immutep Limited (NASDAQ:IMMP) Shares Acquired by BNP Paribas Financial Markets - Defense World
Immutep Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer - GlobeNewswire
Guess which ASX healthcare stock is surging on big FDA news - The Motley Fool
Why 29Metals, Immutep, Insignia, and Perenti shares are pushing higher today - The Motley Fool
FY2027 EPS Estimates for Immutep Limited (NASDAQ:IMMP) Cut by Capital One Financial - American Banking and Market News
Equities Analysts Set Expectations for Immutep Limited’s FY2029 Earnings (NASDAQ:IMMP) - Defense World
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.2% in June - Defense World
Immutep Receives Regulatory Clearance for Phase I Study of - GlobeNewswire
Get in on Immutep Limited ADR’s (IMMP) buy-in window today! - SETE News
Immutep Limited ADR: Weathering Stock Market Storms with 257.67M Market Cap - The InvestChronicle
Examining IMMP’s book value per share for the latest quarter - US Post News
Immutep (IMMP) Up as Combo Therapy Meets Carcinoma Study Goals - Zacks Investment Research
Immutep Limited ADR Inc. (IMMP) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Why Is Australia Based Immutep's Stock Soaring On Friday?Immutep (NASDAQ:IMMP) - Benzinga
Why Ericsson Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
Why Immutep, Kingsgate, Netwealth, and Ora Banda shares are storming higher - The Motley Fool
Why is this ASX healthcare stock rocketing 25% on Friday? - The Motley Fool
Immutep Reports Positive Results in First Line Head and - GlobeNewswire Inc.
Balance Sheet Breakdown: Immutep Limited ADR (IMMP)'s Debt-to-Equity and Long-Term Debt/Eq Ratios – DWinneX - The Dwinnex
Immutep Limited (NASDAQ:IMMP) Short Interest Up 6.6% in June - Defense World
Holdings of Immutep Limited ADR (IMMP) are aligned with the stars – Sete News - SETE News
Market cap of Blue Star Foods Corp [BSFC] reaches 2.18M – now what? – The DBT News - The DBT News
Guggenheim lifts Invivyd Inc [IVVD] price estimate. Who else is bullish? – The DBT News - The DBT News
Chegg Inc [CHGG] stock Downgrade by Jefferies analyst, price target now $4 – The DBT News - The DBT News
Immutep Limited ADR (IMMP) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle
IMMP's price-to-book ratio: An indicator of the company's performance – US Post News - US Post News
Baird cuts Immutep stock target on phase 2b trial results, retains Outperform - Investing.com
Immutep licenses new anti-cancer molecules from Cardiff University - Investing.com India
Short Interest in Immutep Limited (NASDAQ:IMMP) Increases By 5.1% - Defense World
Immutep Limited ADR Inc. (IMMP) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Immutep Limited ADR (IMMP) Stock: A Comprehensive 52-Week Review - The InvestChronicle
Quarterly Snapshot: Quick and Current Ratios for Immutep Limited ADR (IMMP) – DWinneX - The Dwinnex
Immutep slips after stock offering - MSN
Immutep stock slips after share offering (NASDAQ:IMMP) - Seeking Alpha
Stocks of the Hour: Immutep, INOVIQ, Eastern Metals - Finance News Network
Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III Trial - GlobeNewswire
Stocks of the Hour: Adherium, Nanoveu, Nimy Resources - ShareCafe
Immutep shares gain as CapitalOne sets $10 target on cancer drug potential By Investing.com - Investing.com
Stocks of the Hour: Krakatoa Resources, Immutep, ABx Group - Finance News Network
Stocks of Immutep Limited ADR (IMMP) are poised to climb above their peers – Sete News - SETE News
Immutep (NASDAQ:IMMP) Stock Passes Below 50 Day Moving Average of $2.45 - Defense World
Immutep appoints research institute to conduct first-in-human study of IMP761 - Biotech Dispatch
Encouraging results for Immutep's cancer therapies - Finance News Network
11 Best ASX Stocks To Buy Now - Yahoo Finance
10 Best Australian Stocks To Buy - Yahoo Finance
1.61%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):